Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
Clinical trial NCT06202599 · COMPLETED
Trial details
- NCT number
- NCT06202599
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-25
- Primary completion
- 2023-08-29
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.